Factoring in API business’ spinoff + a strong Q1
18/05/22 -"We have updated our model to incorporate the impact of the spin-off of the API (active pharmaceutical ingredient) business, which had listed separately as EUROAPI – now part of the NAV as an equity ..."
Pages
62
Language
English
Published on
18/05/22
You may also be interested by these reports :
22/06/22
However, these expenses are investment into growth and should continue to support Astra’s sector-leading top-line growth in the coming years. ...
15/06/22
Roadshow highlights: CFO Suter shows himself very confident to reach Siegfried’s 2022E guidance and mid-term targets
03/06/22
Sentiment for the current business environment might be far better than expected by many market participants, but question mark on the development ...
02/06/22
We have revised downwards our profitability expectations due to the significant price increases for consumables and single-use products. Compounded ...